New generation of substrates to harness the full power of microorganismsbroad
Bac3Gel · Horizon Europe grant · 2023-07-01–2025-10-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2023-ACCELERATOR-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2023-ACCELERATOROPEN-01. CORDIS record →
Objective
Bac3Gel is a biotech company that develops and distributes advanced substrates to harness the full power of microorganisms. Bac3Gel substrates are the first that combine three-dimensionality with gradients of oxygen, nutrients and physical properties to allow the growth of complex microbial communities and currently unculturable bacteria that depend on these microenvironments to thrive. Our advanced substrates have the power to revolutionise the status quo of microbiology and unlock innovative bacteria-based solutions to solve challenges across multiple bio-based industries. Bac3Gel mission is to ultimately foster the discovery of new antibiotics and bio-based solutions to feed the ever-growing demand for innovative treatments, as well as the development of microbiome-modulating drugs to address 90% of diseases linked to human microbiome imbalance.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| BAC3GEL, LDA. | PT | coordinator | €1,500,712 | Yes |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.